CMC Biopharmaceuticals A/S Appoints Dr. Diana Morgan As Chief Business Officer

Copenhagen, Denmark; March 10, 2006 – CMC Biopharmaceuticals A/S (CMC), a leading provider of contract bio-manufacturing services to the biopharmaceutical industry, has appointed Diana Morgan, PhD as Chief Business Officer.

Back to news